BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/26/17 Novartis (NVS) Zykadia for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
5/26/17 Kite Pharma (KITE) Axicabtagene Ciloleucel for Diffuse Large B-Cell Lymphoma (DLBCL) - NHL Subscribers Only Subscribers Only Subscribers Only
5/26/17 Shire (SHPG) Intuniv Extended Release for Attention Deficit Hyperactivity Disorder (ADHD) Subscribers Only Subscribers Only Subscribers Only
5/25/17 Merck (MRK) Anti-Tau Antibody Program (Teijin/Merck) for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only
5/25/17 Galenica (GALN.VX) Retacrit for Anemia Due to Chronic Renal Failure, Dialysis-Dependent Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/26/17 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
05/27/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/29/17 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
05/29/17 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
05/29/17 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)